Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide treatment showed no significant changes in mice vaginal mucosa.

The hydrogel with Finasteride provides controlled, sustained drug release and improved bioavailability.

The document aimed to understand how certain treatments affect blood vessel growth in rat prostates.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Certain pesticides may delay sexual maturity in teenage boys.

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The DHT immunoassay is unreliable due to high cross-reactivity with testosterone.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

The treatment increased total hair count but wasn't significantly better than placebo.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

The method accurately measures sex hormones in human plasma but can have small errors.

The treatment effectively reduces menopausal symptoms and is well tolerated.

ACA from Alpinia galanga may prevent testosterone-related hair loss.